SEC Form 4 · accession 0001209191-17-066076
ACURA PHARMACEUTICALS, INC · ACUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William G Skelly
Director
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 6:21 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2017 | P | 100,000 | $0.10 | A | 128,345 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting Person is among buyers of shares in a private transaction pursuant to a stock purchase agreement entered into with Galen Partners III, LP, Galen Employee Fund III, LP and Galen Partners International III, LP in connection with their disposition of substantially all of their shares of Issuer.